Healthcare and Life Sciences organizations are turning to Real World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) to develop greater insight into the value of drugs and treatments in clinical practice and patient outcomes.
For these organizations, the ability to efficiently integrate real-world data (RWD) is key to faster time to insight. However, the data itself can present a monumental barrier to understanding because RWD is multi-structured information originating from disconnected sources—including supplementary information collected during RCTs, clinical trials, claims data, registries, EHRs, and patient health surveys—which makes search and discovery a real-world challenge.
The success of HEOR efforts hinges heavily upon your organization’s ability to efficiently integrate, harmonize and analyze this disparate data to achieve greater insights into the underlying causes of disease and to provide the public with cost-effective treatment options that improve patient outcomes—and overall healthcare value.
Join the lively webinar discussion with Dr. Patti Peeples and MarkLogic CTO Bill Fox, as they cover:
Bill Fox, J.D., M.A.
Global CTO Healthcare and Life Sciences, MarkLogic
Patti Peeples, R.Ph., Ph.D.
CEO, healtheconomics.com and Principal Health Economist, HE Institute